Aggregate number of warrants exercisable.

No definition available.

Name:	nmtc_AggregateNumberOfWarrantsExercisable
Namespace Prefix:	nmtc_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of collaborations revenue recognized.

+ References

No definition available.

+ Details

Name:	nmtc_CollaborationsRevenueRecognized
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of revenue recognized previously reported as deferred income not accounted for under Topic 606.

+ References

No definition available.

+ Details

Name:	nmtc_DeferredIncomeRevenueRecognized
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Expected term.

+ References

No definition available.

+ Details

Name:	nmtc_ExpectedTerm
Namespace Prefix:	nmtc_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of fair value of warrants.

+ References

No definition available.

+ Details

Name:	nmtc_FairValueOfWarrants
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of the initial fee paid under the Zimmer development agreement.

+ References

No definition available.

+ Details

Name:	nmtc_InitialExclusivityFee
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Intial fee payment.

+ References

No definition available.

+ Details

Name:	nmtc_IntialFeePayment
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of milestone payment related to the Zimmer agreement.

+ References

No definition available.

+ Details

Name:	nmtc_MilestonePayments
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This amount represents milestone payments to Neuroone

+ References

No definition available.

+ Details

Name:	nmtc_MilestonePaymentsPaid
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

It represent milestone payments to Neuroone.

+ References

No definition available.

+ Details

Name:	nmtc_MilestonePaymentsToNeuroone
Namespace Prefix:	nmtc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- References

No definition available.

+ Details

Name:	nmtc_ZimmerDevelopmentAgreementDetailsLineItems
Namespace Prefix:	nmtc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 35
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848

+ Details

Name:	us-gaap_AdvertisingExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(6))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

+ Details

Name:	us-gaap_BusinessDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	nmtc_TypeOfAgreementAxis=nmtc_DevelopmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=nmtc_ScenarioTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=nmtc_ModifiedConnectorbyApril302021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=nmtc_ModifiedConnectorbySeptember302021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=nmtc_ScenarioOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=nmtc_April302021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=nmtc_OnOrBeforeJune302021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Zimmer Development Agreement (Details) - USD ($)		1 Months Ended	3 Months Ended
Zimmer Development Agreement (Details) - USD ($)	Aug. 02, 2022	Oct. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Zimmer Development Agreement (Details) [Line Items]
Initial fee payment			$ 2,000,000
Aggregate number of warrants exercisable (in Shares)			350,000
Warrants exercise price (in Dollars per share)			$ 3
Fair value of warrants			$ 100,000
Risk-free interest rate			2.90%
Expected volatility percentage			53.50%	56.00%
Expected life			5 years
Expected dividend yield percentage			0.00%	0.00%
Development agreement			$ 5,400,000	$ 6,374
Initial exclusivity fee			2,000,000
Milestone Payments			3,500,000
Product revenue			114,579	33,748
Total advertising expense			53,026	$ 61,335
Development Agreement [Member]
Zimmer Development Agreement (Details) [Line Items]
Revenue recognized		$ 1,455,188
Scenario Two [Member] \| Development Agreement [Member] \| Modified Connector by April 30, 2021 [Member]
Zimmer Development Agreement (Details) [Line Items]
Milestone payments paid	$ 3,500,000
Scenario Two [Member] \| Development Agreement [Member] \| Modified Connector by September 30, 2021 [Member]
Zimmer Development Agreement (Details) [Line Items]
Milestone payments paid	2,000,000
Scenario One [Member] \| Development Agreement [Member] \| April 30, 2021 [Member]
Zimmer Development Agreement (Details) [Line Items]
Milestone payments to Neuroone	$ 1,500,000
Scenario One [Member] \| Development Agreement [Member] \| On or before June 30, 2021 [Member]
Zimmer Development Agreement (Details) [Line Items]
Fair value of warrants			$ 100,000